Optimised labeling, preclinical and initial clinical aspects of CCK-2 receptor-targeting with 3 radiolabeled peptides
- 30 November 2008
- journal article
- Published by Elsevier BV in Nuclear Medicine and Biology
- Vol. 35 (8), 839-849
- https://doi.org/10.1016/j.nucmedbio.2008.09.006
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Macrocyclic chelator-coupled gastrin-based radiopharmaceuticals for targeting of gastrin receptor-expressing tumoursEuropean Journal of Nuclear Medicine and Molecular Imaging, 2008
- Formulation development and manufacturing of a gastrin/CCK-2 receptor targeting peptide as an intermediate drug product for a clinical imaging studyEuropean Journal of Pharmaceutical Sciences, 2007
- Selection of Radiolabeled Gastrin Analogs for Peptide Receptor–Targeted Radionuclide TherapyJournal of Nuclear Medicine, 2007
- 99mTc-labelled HYNIC-minigastrin with reduced kidney uptake for targeting of CCK-2 receptor-positive tumoursEuropean Journal of Nuclear Medicine and Molecular Imaging, 2007
- Improved kinetic stability of DTPA-dGlu as compared with conventional monofunctional DTPA in chelating indium and yttrium: preclinical and initial clinical evaluation of radiometal labelled minigastrin derivativesEuropean Journal of Nuclear Medicine and Molecular Imaging, 2003
- Optimising conditions for radiolabelling of DOTA-peptides with 90Y, 111In and 177Lu at high specific activitiesEuropean Journal of Nuclear Medicine and Molecular Imaging, 2003
- Cholecystokinin‐B (CCK‐B)/gastrin receptor targeting peptides for staging and therapy of medullary thyroid cancer and other CCK‐B receptor expressing malignanciesPeptide Science, 2002
- Cholecystokinin receptor imaging using an octapeptide DTPA-CCK analogue in patients with medullary thyroid carcinomaEuropean Journal of Nuclear Medicine and Molecular Imaging, 2000
- Unsulfated DTPA- and DOTA-CCK analogs as specific high-affinity ligands for CCK-B receptor-expressing human and rat tissues in vitro and in vivo.European Journal of Nuclear Medicine and Molecular Imaging, 1998
- Unexpected high incidence of cholecystokinin-B/gastrin receptors in human medullary thyroid carcinomasInternational Journal of Cancer, 1996